KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Short-term Investments (2016 - 2026)

Halozyme Therapeutics has reported Short-term Investments over the past 14 years, most recently at $8.9 million for Q1 2026.

  • Quarterly Short-term Investments fell 98.45% to $8.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Mar 2026, down 98.45% year-over-year, with the annual reading at $9.0 million for FY2025, 98.13% down from the prior year.
  • Short-term Investments was $8.9 million for Q1 2026 at Halozyme Therapeutics, down from $9.0 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $668.3 million in Q1 2022 and troughed at $8.9 million in Q1 2026.
  • The 5-year median for Short-term Investments is $217.6 million (2023), against an average of $279.8 million.
  • Year-over-year, Short-term Investments skyrocketed 168.4% in 2024 and then tumbled 98.45% in 2026.
  • A 5-year view of Short-term Investments shows it stood at $128.6 million in 2022, then soared by 69.23% to $217.6 million in 2023, then surged by 120.66% to $480.2 million in 2024, then tumbled by 98.13% to $9.0 million in 2025, then decreased by 1.41% to $8.9 million in 2026.
  • Per Business Quant, the three most recent readings for HALO's Short-term Investments are $8.9 million (Q1 2026), $9.0 million (Q4 2025), and $282.3 million (Q3 2025).